Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Depression, Alzheimers sygdom Læsetid: 1 minut(s)Congress highlightsInfographic Depression and an ageing population According to a recent systematic review, the global prevalence of depression in people aged >60... Content action menuShareTestTest 2Test 3
Mental health Video Ellids Kristensen - Seksuelle udfordringer for mennesker med psykiske lidelser Psykisk lidelse kan have konsekvenser for parforhold og seksualitet, og flere undersøgelser har... Content action menuShareTestTest 2Test 3
Depression Læsetid: 2 minut(s) Article Depression in men: less frequent, or just less recognized? International Men’s Day, among other aims, seeks to increase awareness of health challenges... Content action menuShareTestTest 2Test 3
Depression Læsetid: 2 minut(s) Congress highlights One disease or many – the complexity of major depressive disorder Should we consider major depressive disorder as a single disease entity of a collection of... Content action menuShareTestTest 2Test 3
Depression Læsetid: 2 minut(s) Article Why do antidepressants cause emotional blunting and what can be done to resolve it in clinical practice? Emotional blunting describes an indifferent, unresponsive affect and inability to feel emotions... Content action menuShareTestTest 2Test 3
Depression VideoExpert Views Treatment progression for depression and depressive episodes Content action menuShareTestTest 2Test 3
Mental health VideoExpert Views What role should patients play in treatment decision making? Content action menuShareTestTest 2Test 3
Mental health Læsetid: 3 minut(s) Congress highlights Do men and women experience psychiatric disorders differently? There are several known epidemiological differences between the genders in psychiatric disorders.... Content action menuShareTestTest 2Test 3
Depression Læsetid: 3 minut(s) Congress highlights Challenges and perspectives in the management of major depressive disorder: How can we bridge clinical predictors and biomarkers to better treatment outcomes for more patients? Although the past 50 to 60 years of antidepressant drug development focusing on monoamines has... Content action menuShareTestTest 2Test 3